Abiopharma

New Form 8-K - UTAH MEDICAL PRODUCTS INC Filed: 2025-07-24 AccNo: 0001096906-25-001180 Size: 292 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form SCHEDULE 13G/A - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Filed: 2025-07-24 AccNo: 0000947871-25-000682 Size: 11 KB

New Form 6-K - GSK plc Filed: 2025-07-24 AccNo: 0001654954-25-008438 Size: 72 KB

New Form 6-K - GSK plc Filed: 2025-07-24 AccNo: 0001654954-25-008430 Size: 3 MB

New Form 6-K - AURORA CANNABIS INC Filed: 2025-07-24 AccNo: 0001279569-25-000785 Size: 47 KB

New Form 6-K - ASTRAZENECA PLC Filed: 2025-07-24 AccNo: 0001654954-25-008413 Size: 35 KB

New Form 8-K - Protagenic Therapeutics, Inc.\new Filed: 2025-07-24 AccNo: 0001641172-25-020802 Size: 251 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form SCHEDULE 13G/A - NEOGEN CORP Filed: 2025-07-24 AccNo: 0001374170-25-000064 Size: 6 KB

New Form 6-K - ImmunoPrecise Antibodies Ltd. Filed: 2025-07-24 AccNo: 0000950170-25-098173 Size: 48 KB

New Form 8-K - Ikena Oncology, Inc. Filed: 2025-07-24 AccNo: 0001193125-25-163990 Size: 156 KB Item 8.01: Other Events